Experience: Our team is experienced in SDV of study Phases I, II, III for healthy volunteer, patient and Japanese bridging studies for multiple therapeutic areas.
‍
Risk-Based Monitoring: Our monitoring approach incorporates risk-based strategies, allowing for targeted monitoring activities and efficient resource allocation.

Certified CRAs: Our in-house team of Certified Clinical Research Associates (CRAs) ensures high-quality monitoring services and adherence to regulatory requirements.

Eligibility Source Data Verification (SDV) Prior to Randomisation: We emphasise the importance of pre-dose eligibility verification through comprehensive SDV, minimising protocol deviations and ensuring data integrity and patient safety.